The effect of some statins on Glucose blood levels in experimental animals

Author:

Abboud Nour1,Makhous Rana2

Affiliation:

1. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tishreen University, Latakia, Syria.

2. Professor in the Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tishreen University, Latakia, Syria.

Abstract

Statins are HMG-CoA reductase inhibitors, which are widely used as cholesterol-lowering drugs to treat hypercholesterolemia. They are essential in the primary and secondary prevention of CVDs. They are also well tolerated drugs, although there might be some adverse reactions, particularly the new onset of T2DM. As DM, impaired fasting glucose and pre-diabetes are significant cardiovascular risk factors, the purpose of the current work was to study the effects of some statins (pravastatin and pitavastatin) on glucose blood levels in non-diabetic and diabetic mice. Non-diabetic and diabetic female albino mice were treated with pravastatin and pitavastatin once a day for 28 days. Diabetes was induced using alloxan monohydrate (160mg/Kg body weight). Both body weight and fasting blood glucose were measured. IGTT was performed before and after drug treatment. There was no significant statistical difference in body weight between groups before and after 4 weeks of treatment. In addition, we didn’t find any marked change in fasting glucose concentrations of the treated groups in comparison to the control groups of each mouse model. No statistically significant difference was reported when we compared glucose values of IGTT before treatment and at the end of the study for each of the non-diabetic groups. Furthermore, no significant difference was recognized in IGTT results within the diabetic groups before and after drug administration, except for the pravastatin group, which showed a significant decrease in minute 30 of IGTT. We concluded that pravastatin may improve glucose intolerance in diabetic patients. Pitavastatin also may not affect the glycemic status in both models. Both drugs didn’t adversely affect fasting glucose levels in the two mouse models. These findings suggest that pravastatin and pitavastatin may be considered as good choices for patients with DM and hypercholesterolemia.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3